The pharma co. believes that FSD201 may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection... Oct 02
Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients... Oct 02
Gujarat records 1,351 new COVID-19 cases; recovery rate reaches 85.46%... Oct 02
UP govt issues unlock guidelines for next phase of relaxation of Covid-19 lockdown... Oct 02
Fujifilm concludes a manufacturing contract agreement with VLP Therapeutics, for a COVID-19 vaccine formulation ... Oct 02
In a statement, Trump's Physician Dr. Sean Conley said, he received confirmation of the positive tests last evening. ... Oct 02
Secretary (AYUSH) also reviewed the current status of IT initiatives undertaken under the Ayush Grid project. It was observed that in the last two years ... Oct 02
ndia has crossed a landmark milestone by keeping the active cases below the 10 lakh mark in a sustained manner for 10 days in a ... Oct 02
... Oct 02
Cardiac arrest is common in critically ill patients with covid-19 and is associated with poor survival... Oct 02
Avalglucosidase alfa is an investigational enzyme replacement therapy, which, if approved, would offer a potential new standard of care for patients with Pompe disease... Oct 02
Consider menstrual cycle as vital sign of women’s general health, say researchers ... Oct 02
FibroGenesis signs cooperation agreement with R4D Biotech of São Paulo to advance the development of PneumoBlast cell therapy for the treatment of COVID-19 ... Oct 02
Rezūm therapy is a new option for patients who are dissatisfied with their current choices for treating BPH... Oct 02
-Advertisements-
Friday, October 02, 2020
